These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 10571528

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F, Pirson I, Bartek J, Dumont JE, Roger PP.
    Mol Biol Cell; 2000 Mar 18; 11(3):1061-76. PubMed ID: 10712520
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG.
    Circulation; 2000 May 02; 101(17):2022-5. PubMed ID: 10790340
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 02; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation.
    Tanner FC, Meier P, Greutert H, Champion C, Nabel EG, Lüscher TF.
    Circulation; 2000 Apr 25; 101(16):1982-9. PubMed ID: 10779466
    [Abstract] [Full Text] [Related]

  • 7. G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2.
    Vadiveloo PK, Filonzi EL, Stanton HR, Hamilton JA.
    Atherosclerosis; 1997 Aug 25; 133(1):61-9. PubMed ID: 9258408
    [Abstract] [Full Text] [Related]

  • 8. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.
    Takahashi A, Taniguchi T, Ishikawa Y, Yokoyama M.
    Circ Res; 1999 Mar 19; 84(5):543-50. PubMed ID: 10082476
    [Abstract] [Full Text] [Related]

  • 9. Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells.
    Stuart WD, Maeda S, Khera P, Fagin JA, Clemens TL.
    Am J Physiol Endocrinol Metab; 2000 Jul 19; 279(1):E60-7. PubMed ID: 10893323
    [Abstract] [Full Text] [Related]

  • 10. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC, Teng CM, Lin SL, Chen YM, Tsai TJ, Hsieh BS.
    Eur J Pharmacol; 2005 Jul 04; 517(1-2):1-10. PubMed ID: 15950964
    [Abstract] [Full Text] [Related]

  • 11. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ, Higgins T, Jones NC, Rozengurt E.
    Oncogene; 1997 Apr 17; 14(15):1759-66. PubMed ID: 9150381
    [Abstract] [Full Text] [Related]

  • 12. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.
    L'Allemain G, Lavoie JN, Rivard N, Baldin V, Pouyssegur J.
    Oncogene; 1997 Apr 24; 14(16):1981-90. PubMed ID: 9150365
    [Abstract] [Full Text] [Related]

  • 13. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
    Hupfeld CJ, Weiss RH.
    Am J Physiol Endocrinol Metab; 2001 Aug 24; 281(2):E207-16. PubMed ID: 11440895
    [Abstract] [Full Text] [Related]

  • 14. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
    Morisaki H, Ando A, Nagata Y, Pereira-Smith O, Smith JR, Ikeda K, Nakanishi M.
    Exp Cell Res; 1999 Dec 15; 253(2):503-10. PubMed ID: 10585273
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms underlying maintenance of smooth muscle cell quiescence in rat aorta: role of the cyclin dependent kinases and their inhibitors.
    Izzard TD, Taylor C, Birkett SD, Jackson CL, Newby AC.
    Cardiovasc Res; 2002 Jan 15; 53(1):242-52. PubMed ID: 11744034
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells.
    Nathe TJ, Deou J, Walsh B, Bourns B, Clowes AW, Daum G.
    Arterioscler Thromb Vasc Biol; 2002 Aug 01; 22(8):1293-8. PubMed ID: 12171790
    [Abstract] [Full Text] [Related]

  • 17. cAMP inhibits linoleic acid-induced growth by antagonizing p27(kip1) depletion, but not interfering with the extracellular signal-regulated kinase or AP-1 activities.
    Hu ZY, Madamanchi NR, Rao GN.
    Biochim Biophys Acta; 1998 Oct 21; 1405(1-3):139-46. PubMed ID: 9784625
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y.
    Oncogene; 2001 Jun 07; 20(26):3428-36. PubMed ID: 11423993
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.